Matthew Kelsey
Stock Analyst at HC Wainwright & Co.
(1.26)
# 3,467
Out of 4,876 analysts
7
Total ratings
50%
Success rate
-2.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Kelsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Assumes: Buy | $100 | $8.68 | +1,052.07% | 1 | Jun 2, 2025 | |
| ACXP Acurx Pharmaceuticals | Assumes: Buy | $8 | $0.43 | +1,760.47% | 1 | May 15, 2025 | |
| DBVT DBV Technologies | Maintains: Equal-Weight | $260 → $100 | $8.88 | +1,026.13% | 5 | Dec 20, 2018 |
Sensei Biotherapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $100
Current: $8.68
Upside: +1,052.07%
Acurx Pharmaceuticals
May 15, 2025
Assumes: Buy
Price Target: $8
Current: $0.43
Upside: +1,760.47%
DBV Technologies
Dec 20, 2018
Maintains: Equal-Weight
Price Target: $260 → $100
Current: $8.88
Upside: +1,026.13%